Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Anthony M Louder"'
Autor:
Carla V Rodriguez-Watson, Natalie E Sheils, Anthony M Louder, Elizabeth H Eldridge, Nancy D Lin, Benjamin D Pollock, Jennifer L Gatz, Shaun J Grannis, Rohit Vashisht, Kanwal Ghauri, Gina Valo, Aloka G Chakravarty, Tamar Lasky, Mary Jung, Stephen L Lovell, Jacqueline M Major, Carly Kabelac, Camille Knepper, Sandy Leonard, Peter J Embi, William G Jenkinson, Reyna Klesh, Omai B Garner, Ayan Patel, Lisa Dahm, Aiden Barin, Dan M Cooper, Tom Andriola, Carrie L Byington, Bridgit O Crews, Atul J Butte, Jeff Allen
Publikováno v:
PLoS ONE, Vol 18, Iss 2, p e0281365 (2023)
BackgroundAs diagnostic tests for COVID-19 were broadly deployed under Emergency Use Authorization, there emerged a need to understand the real-world utilization and performance of serological testing across the United States.MethodsSix health system
Externí odkaz:
https://doaj.org/article/1d391659fa724fe3a31098caa411fc84
Autor:
Carla V Rodriguez-Watson, Anthony M Louder, Carly Kabelac, Christopher M Frederick, Natalie E Sheils, Elizabeth H Eldridge, Nancy D Lin, Benjamin D Pollock, Jennifer L Gatz, Shaun J Grannis, Rohit Vashisht, Kanwal Ghauri, Camille Knepper, Sandy Leonard, Peter J Embi, Garrett Jenkinson, Reyna Klesh, Omai B Garner, Ayan Patel, Lisa Dahm, Aiden Barin, Dan M Cooper, Tom Andriola, Carrie L Byington, Bridgit O Crews, Atul J Butte, Jeff Allen
Publikováno v:
PLoS ONE, Vol 18, Iss 2, p e0279956 (2023)
BackgroundReal-world performance of COVID-19 diagnostic tests under Emergency Use Authorization (EUA) must be assessed. We describe overall trends in the performance of serology tests in the context of real-world implementation.MethodsSix health syst
Externí odkaz:
https://doaj.org/article/e9a15bc2622142d7b29c87d6a448ed8f
Autor:
Carla V. Rodriguez-Watson, Natalie E. Sheils, Anthony M. Louder, Elizabeth H. Eldridge, Nancy D. Lin, Benjamin D. Pollock, Jennifer L. Gatz, Shaun J. Grannis, Rohit Vashisht, Kanwal Ghauri, Gina Valo, Aloka G. Chakravarty, Tamar Lasky, Mary Jung, Stephen L. Lovell, Jacqueline M. Major, Carly Kabelac, Camille Knepper, Sandy Leonard, Peter J. Embi, William G. Jenkinson, Reyna Klesh, Omai B. Garner, Ayan Patel, Lisa Dahm, Aiden Barin, Dan M. Cooper, Tom Andriola, Carrie L. Byington, Bridgit O. Crews, Atul J. Butte, Jeff Allen
Publikováno v:
PLoS ONE, vol 18, iss 2 February
PloS one, vol 18, iss 2
PloS one, vol 18, iss 2
Background As diagnostic tests for COVID-19 were broadly deployed under Emergency Use Authorization, there emerged a need to understand the real-world utilization and performance of serological testing across the United States. Methods Six health sys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6566377936e48dac081ffa7f6a3ed5a2
https://escholarship.org/uc/item/8rx9p907
https://escholarship.org/uc/item/8rx9p907
Publikováno v:
Journal of Managed Care Pharmacy. 19:374-384
Health plans and pharmacy benefit managers have implemented utilization management strategies for newer type 2 diabetes mellitus (T2DM) medications to control pharmacy expenditures. Little is known about the impact of utilization management strategie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e77d23e61a9667fe6848ebdbc67b27a3
https://doi.org/10.18553/jmcp.2013.19.5.374
https://doi.org/10.18553/jmcp.2013.19.5.374
Autor:
Anthony M, Louder, Amitabh, Singh, Kim, Saverno, Joseph C, Cappelleri, Aaron J, Aten, Andrew S, Koenig, Margaret K, Pasquale
Publikováno v:
American healthdrug benefits. 9(2)
Tofacitinib, an oral Janus kinase inhibitor approved for the treatment of rheumatoid arthritis (RA), provides patients with an alternative to subcutaneously or intravenously administered biologic disease-modifying antirheumatic drugs (DMARDs). Little
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f8b4b9ffe5d7901021c8a086a0a5f9d6
https://pubmed.ncbi.nlm.nih.gov/27182427
https://pubmed.ncbi.nlm.nih.gov/27182427
Autor:
Amanda S Bruno, Jeffrey N Trocio, Daniel Wiederkehr, Younos Abdulsattar, Joette Gdovin, Courtney Brown, Joseph T Dye, Anthony M Louder, Jack Mardekian, Margaret Pasquale
Publikováno v:
Circulation. 130
OBJECTIVE: Examine anticoagulation (AC) treatment in Medicare Advantage Prescription Drug (MAPD) plan members diagnosed with non-valvular atrial fibrillation (NVAF) and at high risk for stroke. METHODS: A retrospective analysis of claims data from a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63cf0f7897eeb5b1727e8641b8f1556c
https://doi.org/10.1161/circ.130.suppl_2.19108
https://doi.org/10.1161/circ.130.suppl_2.19108
Autor:
Margaret K, Pasquale, Anthony M, Louder, Michael C, Deminski, Richard B, Chambers, Seema, Haider
Publikováno v:
The American journal of managed care. 19(9)
To determine the relationship between benefit design, out-of-pocket costs, and prescription reversals, and the impact of reversals on rehospitalizations and total healthcare costs among Medicare members prescribed oral linezolid.Medicare members from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8bec2eff47c3ed92b244a27f4b2756ce
https://pubmed.ncbi.nlm.nih.gov/24304256
https://pubmed.ncbi.nlm.nih.gov/24304256
Autor:
Stephanie A, Stowell, Allison J, Gardner, Joseph S, Alpert, Gerald V, Naccarelli, Thomas P, Harkins, Anthony M, Louder, Leonardo, Tamariz
Publikováno v:
The American journal of managed care. 18(5)
To determine whether changes in physician behavior associated with a continuing medical education (CME) activity on atrial fibrillation (AF) can be measured using an administrative claims database.A retrospective, analytical review of physician pract
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::adeab6f1854844abbfcdaebc6d9db5ef
https://pubmed.ncbi.nlm.nih.gov/22694063
https://pubmed.ncbi.nlm.nih.gov/22694063
Publikováno v:
Pharmacotherapy. 25(8)
Study Objective. To assess the risk of acute pancreatitis in patients receiving various combinations of protease inhibitors, nucleoside reverse transcriptase inhibitors (NRTIs), and nonnucleoside reverse transcriptase inhibitors (NNRTIs) for treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a391d40eb46495d12d4cd66cdcb0a3d
https://pubmed.ncbi.nlm.nih.gov/16207094
https://pubmed.ncbi.nlm.nih.gov/16207094
Autor:
Robert William Sweetman, Elizabeth A. MacLean, Jack Mardekian, Cari Bruins, Gregory Smith, Anthony M. Louder, Margaret K Pasquale, Melea A Ward, Kimberly R. Saverno
Publikováno v:
Journal of Clinical Oncology. 32:e19075-e19075
e19075 Background: Identification of oncogene mutations and gene rearrangements in individuals with non-small cell lung cancer (NSCLC) can help identify candidates for targeted therapy. The objecti...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1edf4aeb1f8d1ca7afdbec387b526af
https://doi.org/10.1200/jco.2014.32.15_suppl.e19075
https://doi.org/10.1200/jco.2014.32.15_suppl.e19075